{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:09:57Z","timestamp":1792188597162,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/iae.0000000000000746","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T10:58:34Z","timestamp":1441882714000},"page":"476-482","source":"Crossref","is-referenced-by-count":11,"title":["BRIDGE ARCH-SHAPED SEROUS RETINAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.1097","volume":"36","author":[{"given":"Franck","family":"Fajnkuchen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon Y.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Thay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Ayrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Delahaye-Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Typhaine","family":"Grenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Nghiem-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Quentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Giocanti-Auregan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0161-6420(96)30512-5","article-title":". Optical coherence tomography of age-related macular degeneration and choroidal neovascularization.","volume":"103","author":"Hee","year":"1996","journal-title":"Ophthalmology"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Group, Martin DF, Maguire MG, et al.. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.","volume":"119","year":"2012","journal-title":"Ophthalmology"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajo.2007.01.028","article-title":". An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.","volume":"143","author":"Fung","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archophthalmol.2009.326","article-title":". Outer retinal tubulation: a novel optical coherence tomography finding.","volume":"127","author":"Zweifel","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1111\/j.1755-3768.2011.02144.x","article-title":". Outer retinal cysts in age-related macular degeneration.","volume":"89","author":"Wolff","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajo.2010.02.019","article-title":". Retinal pseudocysts in age-related geographic atrophy.","volume":"150","author":"Cohen","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3341\/kjo.2012.26.5.347","article-title":"Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography.","volume":"26","author":"Kim","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajo.2007.04.007","article-title":"Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.","volume":"144","author":"Yamaguchi","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":". Risk of scar in the comparison of age-related macular degeneration treatments trials.","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":". Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":". Ranibizumab versus verteporfin for neovascular age-related macular degeneration.","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","article-title":". Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.","volume":"145","author":"Regillo","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Investigators, Chakravarthy U, Harding SP, et al.. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.","volume":"119","year":"2012","journal-title":"Ophthalmology"},{"key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ajo.2008.12.005","article-title":". Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration.","volume":"147","author":"Rothenbuehler","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2009.04.001","article-title":". Results of one-years treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.","volume":"148","author":"Cohen","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjo.2009.170670","article-title":". Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting.","volume":"94","author":"Querques","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/IAE.0b013e318240a516","article-title":". Causes of unsuccessful ranibizumab treatment in exudative age-related macular degeneration in clinical settings.","volume":"32","author":"Cohen","year":"2012","journal-title":"Retina"},{"key":"R18-6-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ophtha.2010.07.011","article-title":". Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials.","volume":"118","author":"Rosenfeld","year":"2011","journal-title":"Ophthalmology"},{"key":"R19-6-20210130","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00417-013-2338-z","article-title":". Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010.","volume":"251","author":"Cohen","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:11:35Z","timestamp":1620954695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201603000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000746","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}